| Financial Year |
March 31 2023 |
| Monetary Funds |
264,784,539.64 |
| Held-for-trading Financial Assets |
80,107,232.87 |
| Notes Receivable |
159,227,593.28 |
| Accounts Receivable |
281,873,885.81 |
| Advances to Suppliers |
29,872,757.45 |
| Other Receivables |
378,460.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
322,761,080.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,501,461.11 |
| Total Current Assets |
1,195,291,375.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
368,944,445.85 |
| Under-construction Projects |
281,610,248.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,816,957.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,875,346.62 |
| Other Non-Current Assets |
12,008,901.91 |
| Sub-Total of Non-Current Assets |
691,255,900.04 |
| Total Assets |
1,886,547,275.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
140,126,775.28 |
| Accounts Payable |
333,415,777.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,699,417.51 |
| Taxes Payable |
1,407,809.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,404,941.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
919,245.84 |
| Sub-Total of Current Liabilities |
531,875,052.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,535,601.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
62,872,138.28 |
| Total Liabilities |
594,747,190.68 |
| Paid-In Capital(Or Share Stock) |
209,066,666.00 |
| Capital Surplus |
645,913,012.47 |
| Surplus Reserve |
152,642,008.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
284,178,398.36 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,291,800,085.25 |
| Owner's Equity（Stockholder's Equity） |
1,291,800,085.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,886,547,275.93 |
